of an appropriate antifungal as an eluting depot in the frontal sinus is worth considering also. Although voriconazole is a highly effective agent for treating such infections in people, when used systemically in cats there seems to be a high risk of adverse events, especially neurological side effects. 14, 20 The widespread use of molecular techniques to augment classical mycology has recently contributed to our understanding of these infections. The Aspergillus section Fumigati contains 10 Aspergillus species and around 23 Neosartorya species, 21 many of which are known pathogens. The term Neosartorya refers to the teleomorph (sexual state), while Aspergillus refers to the anamorph (asexual state) of the corresponding species -and this nomenclature makes describing infections somewhat confusing. Nonetheless, sequencing techniques can discriminate fungal species within this section that may be indistinguishable using standard phenotypic methods, but that display marked differences in their clinical features and therapeutic requirements. The first breakthrough was when a panfungal PCR developed at Westmead Hospital in Sydney, Australia, demonstrated that a cat with sino-orbital mycosis had a Neosartorya pseudofischeri infection, 17, 22 a finding echoed in cases from Japan (Aspergillus udagawae/Neosartorya udagawae) 11 and the UK (Neosartorya aureola). 16 In those cases in which the fungus has been identified solely on morphology, it is not always clear whether Aspergillus fumigatus or in fact a closely related species was responsible for the infection. However, the evidence suggests that when filamentous fungi are restricted to the nasal cavity, perhaps with limited extension to the nasopharynx or nasal bridge (Fig 3) , A fumigatus is most likely to be involved. This would explain why such cases can respond to topical therapy using clotrimazole 'soaks', if these are given before the underlying bone is breached. 12, 23 By contrast, where there is documented extension to the orbit, eye, brain or oral cavity, one should be suspicious of another species (eg, N pseudofischeri, 17 N udagawae, 11 N aureola, 16 Aspergillus lentulus 17 ). This is especially germane because these close relatives of A fumigatus can be very resistant to both amphotericin B and the older azole drugs. 24, 25 Thus, definitive identification of the infectious agent may have important implications for treatment choices and disease prognosis. A multi-institutional study in Australia is currently bringing together these various clinical and laboratory observations. 17 Case studies, such as the one in this issue of JFMS, 2 focus our attention on a number of pertinent issues (see box). Added to which, there is an urgent need to determine pharmacokinetic data in cats for new antifungal agents, such as posaconazole and caspofungin, and for older agents such as amphotericin B and its newer formulations. To make progress in answering these questions, veterinarians need the help of laboratory scientists and human infectious disease clinicians who are interested in veterinary mycology and based at reference laboratories in medical mycology with expertise in both classical mycology and molecular methods.
Four outstanding examples are listed as useful contacts on page 671. Finally, veterinarians in the UK in need of assistance with acquiring antifungals should e-mail admin@aspergillus. org.uk (citing 'Antifungals' in the subject line). ✜ What factors underlie the marked differences in pathogenicity of these organisms? -Why does A fumigatus tend not to invade the orbit or oral cavity while the closely related Neosartorya species do? Is this related to preferential deposition of ascospores in certain parts of the nasal cavity? -Why do Cryptococcus species tend to spread to the nasal bridge and cribriform plate in the cat, but rarely to the orbit or oral cavity (they do not show this bias in dogs), 26 
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